FAA Grants Final Approval For Long Delayed Boeing 737 MAX 10
Boeing (BA) received FAA approval for the 737 MAX 10, clearing deliveries to begin in early 2024. The MAX 10, with a 230-passenger capacity, represents 31% of Boeing's 737 backlog. Boeing's stock (BA) is down 13% over six months, trading at $190 with a $267 price target. Q2 revenue rose 8% to $24.6 billion, with positive free cash flow of $631 million.
How this was made
The 30-second read
Why it matters
Clears a major regulatory hurdle, enabling Boeing to begin deliveries and potentially improve cash flow, though market reaction may be muted.
Market read
Regulatory approval is a primary catalyst for Boeing, likely supporting the stock despite limited immediate price movement.
What to watch
Potential delays in certification by Transport Canada and European regulators could temper the upside.
Background
The FAA's final approval ends a multi‑year certification delay for the 737 MAX 10, the largest variant of Boeing's best‑selling jet.
Ticker impact
FAA granted final approval for the Boeing 737 MAX 10, clearing the way for deliveries and removing a major regulatory hurdle.
likely modest upward pressure as the market prices in the cleared hurdle
Regulatory clearance is a material catalyst for a large-cap aerospace maker; however, the article notes the news was largely expected, limiting upside.
Market effects
May boost the broader commercial aerospace sector as competitors lose a regulatory headwind.
U.S. aerospace stocks could see slight gains; Canadian and European peers may benefit from renewed demand.
Regulatory approval of a major aircraft model is globally relevant, potentially influencing airline ordering cycles worldwide.
Counterpoint
If the approval was already priced in, the stock could stall or even dip on profit-taking.
Key entities
- CompanyBoeing
U.S. aerospace manufacturer (ticker BA) receiving FAA approval for the 737 MAX 10.
- RegulatorFAA
U.S. Federal Aviation Administration granting final certification.
